• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

XNPT:US

4.2000 USD 0.0200 0.48%

As of 20:10:00 ET on 04/17/2014.

Snapshot for XenoPort Inc (XNPT)

Open: 4.1600 Day's Range: 4.0300 - 4.2700 Volume: 405,338
Previous Close: 4.1800 52wk Range: 3.8900 - 7.5900 1-Yr Rtn: -42.39%

Stock Chart for XNPT

No chart data available.
  • XNPT:US 4.2000
  • 1D
  • 1M
  • 1Y
4.1800
Interactive XNPT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XNPT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.7920
Est. EPS (USD) (12/2014) -1.3910
Est. PEG Ratio -
Market Cap (M USD) 258.44
Shares Outstanding (M) 61.53
30 Day Average Volume 464,309
Price/Book (mrq) 3.7390
Price/Sale (ttm) 25.1629
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XNPT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XNPT

XenoPort Inc. is biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of existing drugs.

Ronald W BarrettCEO/FounderVincent J AngottiExecutive VP/COO
Gianna M Bosko "Gia"Senior VP/Chief Legal Ofcr/SecyRichard KimSenior VP:Clinical Dev & Medical Affairs
More Company Profile & Key Executives for XNPT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil